targeting methionine auxotrophy cancer discovery exploration pubmed ncbi abstract introduction amino acid auxotrophy metabolic defect renders cancer incapable surviving amino acid depleted conditions exploited explored therapeutic cancer early clinical data asparagine arginine-depleting drugs demonstrated low toxicity efficacy melanoma hepatocellular carcinoma acute lymphoblastic leukemia methionine auxotrophy niche exploration targeting cancers areas covered review explore discovery methionine auxotrophy vitro vivo patient data targeting cancer methionine depletion end small discussion bioengineering pegylation red blood cell encapsulation mechanisms decreasing immunogenicity methionine-depleting drugs hope provide platform future pharmacology toxicology cytotoxicity studies methionine depletion therapy drugs expert opinion methionine auxotrophy viable target extensive research addressing normal versus cancer cell toxicity conducted research conducted molecular mechanism methionine depletion therapy finally methods developed decrease immunogenicity methionine-depleting drugs current issue protein therapeutics 
